-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/11 cls AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) Baird Christopher Raymond Downgrade Neutral (from outperform) -16% $13.25 Ladenburg …
Published on 5/14/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/4 cls Actelion Ltd. (SIX:ATLN) UBS Guillaume van Renterghem Price target Buy 18% CHF39.90 van Renterghem raised his target to CHF61…
Published on 5/7/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/27 cls Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) Brean Murray Jonathan Aschoff Price target Buy -1% $90.56 Jefferies Eun Yang …
Published on 4/30/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/20 cls Endocyte Inc. (NASDAQ:ECYT) Baird Christopher Raymond Price target Neutral 95% $7.41 Leerink Howard Liang Price target …
Published on 4/23/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/13 cls Cardiome Pharma Corp. (TSX:COM; NASDAQ:CRME) Bloom Burton Philippa Flint Upgrade Hold (from sell) -6% $0.59 Flint upgraded …
Published on 4/16/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/5 cls Aeterna Zentaris Inc. (TSX:AEZ; NASDAQ:AEZS) Bloom Burton Philippa Flint Downgrade Sell (from hold) -63% $0.80 Rodman Reni …
Published on 4/9/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/30 cls Active Biotech AB (SSE:ACTI) Jefferies Peter Welford Upgrade Hold (from underperform) 0% SEK46.60 Welford also raised his …
Published on 4/2/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/23 cls Addex Therapeutics (SIX:ADXN) Jefferies Peter Welford Upgrade Buy (from hold) 65% CHF10.50 Welford also raised his target to…
Published on 3/26/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/16 cls Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) Cowen Steve Scala Downgrade Neutral (from outperform) -51% $3.17 Deutsche Bank …
Published on 3/19/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/9 cls Celldex Therapeutics Inc. (NASDAQ:CLDX) Roth Capital Partners Joseph Pantginis Price target Buy 3% $3.90 Pantginis raised his…
Published on 3/12/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/2 cls Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Leerink Howard Liang Price target Outperform -3% $14.68 Liang raised his target to $…
Published on 3/5/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/24 cls Gentium S.p.A. (NASDAQ:GENT) ThinkEquity Mani Mohindru Upgrade Buy (from sell) 1% $8.68 Mohindru also raised his target to $…
Published on 2/27/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/17 cls BG Medicine Inc. (NASDAQ:BGMD) Ladenburg Thalmann Kevin DeGeeter Price target Buy -7% $7.90 DeGeeter raised his target to $…
Published on 2/20/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/10 cls Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) Baird Christopher Raymond Upgrade Outperform (from neutral) 6% $83.45 Deutsche …
Published on 2/13/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/3 cls Alkermes plc (NASDAQ:ALKS) Baird Thomas Russo Price target Neutral 0% $19.15 Leerink Steve Yoo Price target Outperform …
Published on 2/6/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/27 cls Gilead Sciences Inc. (NASDAQ:GILD) RBC Capital Markets Michael Yee Price target Market outperform 3% $48.72 Yee raised his …
Published on 1/30/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/20 cls Amgen Inc. (NASDAQ:AMGN) Baird Christopher Raymond Price target Market outperform 3% $69.57 Raymond raised his target to $75…
Published on 1/23/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/13 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Baird Thomas Russo Price target Market outperform 56% $12.37 Leerink Howard …
Published on 1/16/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/6 cls Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) RBC Capital Markets Jason Kantor Other Market outperform -19% $13.97 Kantor …
Published on 1/9/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/30 cls Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) Needham Alan Carr Upgrade Buy (from hold) -3% $8.54 Carr also set a $10 target…
Published on 1/2/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/16 cls BioSante Pharmaceuticals Inc. (NASDAQ:BPAX) Jefferies Graig Suvannavejh Downgrade Hold (from buy) -82% $0.45 Leerink …
Published on 12/19/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/9 cls Omeros Corp. (NASDAQ:OMER) Rodman Elemer Piros Upgrade Market outperform (from market perform) 3% $4.04 Piros also set a $13…
Published on 12/12/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/2 cls Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) Wedbush Duane Nash Upgrade Market outperform (from neutral) 19% $6.48 Nash also …
Published on 12/5/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/18 cls Alimera Sciences Inc. (NASDAQ:ALIM) Cowen Simos Simeonidis Downgrade Neutral (from market outperform) $1.29 -34% Simeonidis…
Published on 11/21/2011
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/11 cls Inhibitex Inc. (NASDAQ:INHX) Deutsche Bank Robyn Karnauskas Price target Buy 9% $9.29 Karnauskas raised her target to $15 …
Published on 11/14/2011